I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Selumetinib: the first ever approved drug for neurofibromat..:
Sabyasachi Mukhopadhyay (1534564)
;
Arpita Maitra (10270172)
;
Shouvik Choudhury (10270175)
https://figshare.com/articles/journal_contribution/Selumetinib_the_first_ever_approved_drug_for_neurofibromatosis-1_related_inoperable_plexiform_neurofibroma/14179229. , 2021
Link:
https://doi.org/10.6084/m9.figshare.14179229.v1
RT Journal T1
Selumetinib: the first ever approved drug for neurofibromatosis-1 related inoperable plexiform neurofibroma
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_14179229&Exemplar=1&LAN=DE A1 Sabyasachi Mukhopadhyay (1534564) A1 Arpita Maitra (10270172) A1 Shouvik Choudhury (10270175) YR 2021 K1 Biochemistry K1 Medicine K1 Cell Biology K1 Genetics K1 Physiology K1 Pharmacology K1 Immunology K1 Cancer K1 Neurofibroma K1 Tumour K1 Neurological disorder JF https://figshare.com/articles/journal_contribution/Selumetinib_the_first_ever_approved_drug_for_neurofibromatosis-1_related_inoperable_plexiform_neurofibroma/14179229 LK http://dx.doi.org/https://doi.org/10.6084/m9.figshare.14179229.v1 DO https://doi.org/10.6084/m9.figshare.14179229.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)